CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-07 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +2,250 | $37.71 | $85K | 15,233 |
| 2023-03-07 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −1,170 | $37.71 | $44K | 14,063 |
| 2023-03-07 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −2,250 | 4,498 | ||
| 2023-03-07 | Dillard James E III EVP & President CSCA | Option exercise | +5,537 | $37.71 | $209K | 36,628 |
| 2023-03-07 | Dillard James E III EVP & President CSCA | Shares withheld for taxes | −2,498 | $37.71 | $94K | 34,130 |
| 2023-03-07 | Dillard James E III EVP & President CSCA | Option exercise · Restricted Stock Units | −5,537 | 11,074 | ||
| 2023-03-06 | Farrington Thomas EVP and CIO | Grant or award · Restricted Stock Units | +5,641 | 5,641 | ||
| 2023-03-06 | Bezerra Eduardo Guarita EVP & Chief Financial Officer | Grant or award · Restricted Stock Units | +14,610 | 14,610 | ||
| 2023-03-06 | HANSON KYLE EVP & General Counsel | Grant or award · Restricted Stock Units | +10,552 | 10,552 | ||
| 2023-03-06 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Grant or award · Restricted Stock Units | +6,899 | 6,899 | ||
| 2023-03-06 | Andersen Svend EVP & President CHCI | Grant or award · Restricted Stock Units | +11,364 | 11,364 | ||
| 2023-03-06 | KESSLER MURRAY S CEO | Grant or award · Restricted Stock Units | +79,140 | 79,140 | ||
| 2023-03-06 | Willis Robert EVP & CHRO | Grant or award · Restricted Stock Units | +5,276 | 5,276 | ||
| 2023-03-06 | Quinn Grainne EVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +5,276 | 5,276 | ||
| 2023-03-06 | Dillard James E III EVP & President CSCA | Grant or award · Restricted Stock Units | +12,175 | 12,175 | ||
| 2023-03-06 | Ives Alison EVP & Chief Scientific Officer | Grant or award · Restricted Stock Units | +6,088 | 6,088 | ||
| 2023-03-03 | Dillard James E III EVP & President CSCA | Grant or award | +10,277 | $38.75 | $398K | 33,215 |
| 2023-03-03 | Dillard James E III EVP & President CSCA | Shares withheld for taxes | −4,690 | $38.75 | $182K | 28,525 |
| 2023-03-03 | Dillard James E III EVP & President CSCA | Option exercise | +1,995 | $38.75 | $77K | 30,520 |
| 2023-03-03 | Dillard James E III EVP & President CSCA | Shares withheld for taxes | −900 | $38.75 | $35K | 29,620 |
Page 26 of 27 · 524 trades